Log in to save to my catalogue

Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel inj...

Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel inj...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9a7dc9e654854869abd3b5de20cb4578

Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes

About this item

Full title

Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes

Publisher

New Zealand: Dove Medical Press Limited

Journal title

International journal of nanomedicine, 2014-01, Vol.9 (Issue 1), p.3527-3538

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Since the availability of recombinant human growth hormone (rhGH) enabled the application of human growth hormone both in clinical and research use in the 1980s, millions of patients were prescribed a daily injection of rhGH, but noncompliance rates were high. To address the problem of noncompliance, numerous studies have been carried out, involvin...

Alternative Titles

Full title

Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9a7dc9e654854869abd3b5de20cb4578

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9a7dc9e654854869abd3b5de20cb4578

Other Identifiers

ISSN

1178-2013,1176-9114

E-ISSN

1178-2013

DOI

10.2147/IJN.S63507

How to access this item